Latest news
Former BioNTech Exec Launches Cancer Surveillance Firm Bios Life With $25M Seed Funding - citybizcitybiz · Tue, 11 Aug 2026 10:02:11 GMTBios Life leaves stealth with $25M and a Tempus alliance for cancer surveillance - The Next WebThe Next Web · Tue, 11 Aug 2026 08:12:04 GMTBios Life emerges from stealth with $25M to build digital twins for cancer screening - Tech Funding NewsTech Funding News · Tue, 11 Aug 2026 07:00:40 GMTPoint2 collects $60M, Bernhard's $1B Bowman buy, Jazz's $820M epilepsy deal - AxiosAxios · Mon, 10 Aug 2026 19:23:51 GMTBios Life Emerges from Stealth with $25M and Partners with Tempus to Personalize Cancer Screening and Surveillance - einpresswire.comeinpresswire.com · Mon, 10 Aug 2026 17:21:00 GMTEx-BioNTech execs launch 'AI-native' cancer company - pharmaphorumpharmaphorum · Mon, 10 Aug 2026 17:05:25 GMTExclusive: BioNTech vets get $25M seed funding for virtual cancer surveillance startup - Endpoints NewsEndpoints News · Mon, 10 Aug 2026 11:00:00 GMT